Basic Information
PANTOSALA POWDER FOR SOLUTION FOR INJECTION 40 MG/VIAL
INJECTION, POWDER, FOR SOLUTION
Regulatory Information
SIN14860P
October 6, 2015
Prescription Only
Therapeutic
INTRAVENOUS
August 10, 2023
June 3, 2025
XA02BC02
Company Information
Active Ingredients
Strength: 40 mg/ vial
Detailed Information
Contraindications
**4.3 Contraindications** Pantoprazole i.v. should generally not be used in cases of known hypersensitivity to one of the constituents of pantoprazole i.v. Pantoprazole, like other PPIs, should not be co-administered with atazanavir (See section 4.5 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_).
Indication Information
**4.1 Therapeutic indications** PANTOSALA 40 mg is indicated in adults for treatment of short-term use for symptomatic improvement and healing of gastrointestinal diseases which require a reduction in acid secretion: - Moderate to severe reflux oesophagitis. - Gastric and duodenal ulcer.